Clinical trial

Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations

NCT01306461

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE3

Study timeline

Study start (unknown)2011-03-01Date precision: month

Registry last updated2012-06-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ocular Hypertensionunresolved

Open-angle Glaucomaunresolved

Interventions

Timolol and TafluprostDRUG

Fixed Dose Combination of tafluprost and timololDRUG

Sponsors & collaborators

Santen Oylead sponsor

Mapped research locations

DebrecenHungary1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01306461 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.